Research Article

You have full text access to this OnlineOpen article

Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint

  1. Ahuva Nissim1,*,
  2. Paul G. Winyard2,
  3. Valerie Corrigall3,
  4. Rewas Fatah1,
  5. David Perrett1,
  6. Gabriel Panayi3,†,
  7. Yuti Chernajovsky1

Article first published online: 2 DEC 2005

DOI: 10.1002/art.21479

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 52, Issue 12, pages 3829–3838, December 2005

Additional Information

How to Cite

Nissim, A., Winyard, P. G., Corrigall, V., Fatah, R., Perrett, D., Panayi, G. and Chernajovsky, Y. (2005), Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint. Arthritis & Rheumatism, 52: 3829–3838. doi: 10.1002/art.21479

Author Information

  1. 1

    University of London, London, UK

  2. 2

    Universities of Exeter and Plymouth, St. Luke's Campus, Exeter, UK

  3. 3

    King's College, Guy's Hospital, London, UK

  1. †

    Dr. Panayi has received consulting fees (less than $10,000 per year) from MSD, Abbott, Roche, and Novartis.

*Bone and Joint Research Unit, William Harvey Research Institute, Barts and The London, Queen Mary's School of Medicine and Dentistry, University of London, Charterhouse Square, London EC1M 6BQ, UK

Publication History

  1. Issue published online: 2 DEC 2005
  2. Article first published online: 2 DEC 2005
  3. Manuscript Accepted: 7 SEP 2005
  4. Manuscript Received: 2 MAR 2005

Funded by

  • Arthritis Research Campaign (UK)
  • Research Advisory Board of Barts
  • The London School of Medicine and Dentistry

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (158K)

REFERENCES

  • 1
    Feldmann M, Maini RM. Anti-TNFα therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001; 19: 163–96.
  • 2
    Gilston V, Blake DR, Winyard PG. Inflammatory mediators, free radicals and gene transcription. In: WinyardPG, BlakeDR, EvansCH, editors. Free radicals and inflammation. Boston: Birkhauser; 2000. p. 83–98.
  • 3
    Tchetverikov I, Ronday HK, van El B, Kiers GH, Verzijl N, te Koppele JM, et al. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis 2004; 63: 881–3.
  • 4
    Winrow VR, Winyard PG, Morris CJ, Blake DR. Free radicals in inflammation: second messengers and mediators of tissue destruction. Br Med Bull 1993; 49: 506–22.
  • 5
    Winyard PG, Zhang Z, Blake DR. Free radicals in rheumatoid arthritis: redox regulation of gene transcription and proteolytic tissue destruction. In: ThomasCE, editor. Oxygen radicals and the disease process. Amsterdam: Hardwood Academic; 1997. p. 85–99.
  • 6
    Frears E, Zhang Z, Blake DR, O'Connell J, Winyard PG. Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Lett 1996; 381: 21–4.
  • 7
    Yoshihara Y, Obata K, Fujimoto N, Yamishita K, Hayakawa T, Shimmei M. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinase–1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 969–75.
    Direct Link:
  • 8
    Taylor DJ, Cheung NT, Dawes PT. Increased serum proMMP-3 in inflammatory arthritides: a potential indicator of synovial inflammatory monokine activity. Ann Rheum Dis 1994; 53: 768–72.
  • 9
    Paul RG, Bailey AJ. Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. Int J Biochem Cell Biol 1996; 28: 1297–310.
  • 10
    Newkirk MM, Goldbach-Mansky R, Lee J, Hoxworth J, McCoy A, Yarboro C, et al. Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis. Arthritis Res Ther 2003; 5: 82–90.
  • 11
    Drinda SF, Canet CC, Petrow P, Brauer R, Huttich C, Stein G, et al. Identification of the advanced glycation end products N(epsilon)-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis. Ann Rheum Dis 2002; 61: 488–92.
  • 12
    Chen JR, Takahashi M, Suzuki M, Kushida K, Miyamoto S, Inoue T. Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford) 1999; 38: 1275–8.
  • 13
    Holmdahl R, Rubin K, Klareskog L, Larsson E, Wigzell H. Characterization of the antibody response in mice with type II collagen–induced arthritis, using monoclonal anti–type II collagen antibodies. Arthritis Rheum 1986; 29: 400–10.
    Direct Link:
  • 14
    Stuart JM, Cremer MA, Townes AS, Kang AH. Type II collagen-induced arthritis in rats: passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med 1982; 155: 1–16.
  • 15
    Jasin HE. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1985; 28: 241–8.
    Direct Link:
  • 16
    Londei M. Persistence of collagen type II specific T cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci U S A 1989; 86: 636–40.
  • 17
    Grinnell S, Yoshida K, Jasin HE. Responses of lymphocytes of patients with rheumatoid arthritis to IgG modified by oxygen radicals or peroxynitrite. Arthritis Rheum 2005; 52: 80–3.
    Direct Link:
  • 18
    Corthay A, Backlund J, Holmdahl R. Role of glycopeptide-specific T cells in collagen-induced arthritis: an example how post-translational modification of proteins may be involved in autoimmune disease. Ann Med 2001; 33: 456–65.
  • 19
    Rogers GE, Harding HW, Llewellyn-Smith IJ. The origin of citrulline-containing proteins in the hair follicle and the chemical nature of trichohyalin, an intracellular precursor. Biochim Biophys Acta 1977; 495: 159–75.
  • 20
    Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741–9.
    Direct Link:
  • 21
    Burkhardt H, Sehnert B, Bockermann R, Engstrom A, Kalden JR, Holmdahl R. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur J Immunol 2005; 35: 1643–52.
    Direct Link:
  • 22
    Holmdahl R, Bockermann R, Backlund J, Yamada H. The molecular pathogenesis of collagen-induced arthritis in mice: a model for rheumatoid arthritis. Ageing Res Rev 2002; 1: 135–47.
  • 23
    Ronnelid J, Lysholm J, Engstrom-Laurent A, Klareskog L, Heyman B. Local anti–type II collagen antibody production in rheumatoid arthritis synovial fluid: evidence for an HLA–DR4–restricted IgG response. Arthritis Rheum 1994; 37: 1023–9.
    Direct Link:
  • 24
    Clague RB, Morgan K, Reynolds I, Williams HJ. The prevalence of serum IgG antibodies to type II collagen in American patients with rheumatoid arthritis. Br J Rheumatol 1994; 33: 336–8.
  • 25
    Morgan K, Clague RB, Reynolds I, Davis M. Antibodies to type II collagen in early rheumatoid arthritis. Br J Rheumatol 1993; 32: 333–5.
  • 26
    Cook AD, Rowley MJ, Mackay IR, Gough A, Emery P. Antibodies to type II collagen in early rheumatoid arthritis: correlation with disease progression. Arthritis Rheum 1996; 39: 1720–7.
    Direct Link:
  • 27
    Cook AD, Mackay IR, Cicuttini FM, Rowley MJ. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 1997; 24: 2090–6.
  • 28
    Kim H, Berek C. B cells in rheumatoid arthritis. Arthritis Res 2000; 2: 126–31.
  • 29
    Miller EJ. Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin. Biochemistry 1972; 26: 4903–9.
  • 30
    Halliwell B, Gutteridge JM. Biologically relevant metal ion-dependent hydroxyl radical generation. FEBS Lett 1992; 307: 108–12.
  • 31
    Hawkins CL, Brown BE, Davies MJ. Hypochlorite- and hypobromite-mediated radical formation and its role in cell lysis. Arch Biochem Biophys 2001; 395: 137–45.
  • 32
    Hawkins CL, Rees MD, Davies MJ. Superoxide radicals can act synergistically with hypochlorite to induce damage to proteins. FEBS Lett 2002; 510: 41–4.
  • 33
    Bailey A, Sims T, Avery N, Halligan E. Non-enzymic glycation of fibrous collagen: reaction products of glucose and ribose. Biochem J 1995; 305: 385–90.
  • 34
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24.
    Direct Link:
  • 35
    Andriopoulos NA, Mestecky J, Miller EJ, Bradley EL. Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum 1976; 19: 613–7.
    Direct Link:
  • 36
    Kim WU, Cho ML, Jung YO, Min SY, Park SW, Min DJ, et al. Type II collagen autoimmunity in rheumatoid arthritis. Am J Med Sci 2004; 327: 202–11.
  • 37
    Terato K, de Armey DA, Ye XJ, Griffiths MM, Cremer MA. The mechanism of autoantibody formation to cartilage in rheumatoid arthritis: possible cross-reaction of antibodies to dietary collagens with autologous type II collagen. Clin Immunol Immunopathol 1996; 79: 142–54.
  • 38
    Kim WU, Yoo WH, Park W, Kang YM, Kim SI, Park JH, et al. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. J Rheumatol 2000; 3: 575–81.
  • 39
    Hunt JV, Wolff SP. Oxidative glycation and free radical production: a causal mechanism of diabetic complications. Free Radic Res Commun 1991; 12: 115–23.
  • 40
    Dean RT, Wolff SP, McElligott MA. Histidine and proline are important sites of free radical damage to proteins. Free Radic Res Commun 1989; 7: 97–103.
  • 41
    Heinecke JW, Li W, Francis GA, Goldstein JA. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest 1993; 91: 2866–72.
  • 42
    Daumer KL, Khan A, Steinbeck MJ. Chlorination of pyridinium compounds. J Biol Chem 2000; 275: 34681–92.
  • 43
    Hawkins CL, Davies MJ. Hypochlorite induced damage to proteins: formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation. Biochem J 1998; 332: 617–25.
  • 44
    Olszowski S, Mak P, Olszowska E, Janusz M. Collagen type II modification by hypochlorite. Acta Biochim Pol 2003; 50: 471–9.
  • 45
    Davies JM, Horwitz DA, Davies KJ. Potential roles of hypochlorous acid and N-chloroamines in collagen breakdown by phagocytic cells in synovitis. Free Radic Biol Med 1993; 15: 637–43.
  • 46
    Herce-Pagliai C, Kotecha S, Shuker DE. Analytical methods for 3-nitrotyrosine as a marker of exposure to reactive nitrogen species. Nitric Oxide 1998; 2: 324–36.
  • 47
    Panayi G, Corrigall V. BiP: a new biologic immunomodulator for the treatment of rheumatoid arthritis. Autoimmun Rev 2004; Suppl 1: S16–7.
  • 48
    Pejovic M, Stankovic A, Mitrovic DR. Determination of the apparent synovial permeability in the knee joint of patients suffering from osteoarthritis and rheumatoid arthritis. Br J Rheumatol 1995; 34: 520–4.
  • 49
    Doyle HA, Mamula MJ. Posttranslational protein modifications: new flavors in the menu of autoantigens. Curr Opin Rheumatol 2002; 3: 244–9.
View Full Article (HTML) Get PDF (158K)